Parallax Health Sciences Stock Predictions

Healthcare > Medical - Healthcare Information Services

Buy PRLX

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jan 13, 2022

Currently predicting for Mon, 15 Jun 2026

PRLX Live board

Community Bull/Bear

Target Next close

Join the PRLX prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

PRLX Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For PRLX

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

PRLX Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT PARALLAX HEALTH SCIENCES, INC.

Parallax Health Sciences, Inc. builds and expands an integrated digital healthcare network with products and services that provide remote communication, diagnosis, treatment, and monitoring of patients. The company offers remote healthcare products, including patent pending software and mobile apps, and other services, as well as electronic kits and devices from third-party licensed platforms that are designated towards a patient's primary health...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
EAT $140.46	13.43%	Jun 05
TPR $140.47	4.95%	Jun 04
LITE $905.00	1.83%	Jun 01
RUN $12.83	0.468%	May 06
GLBE $31.61	3.54%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by